Experienced in Hypophosphatasia (HPP)

Mikhail M. Kostik

Saint Petersburg, SPE, RU 
Clinical Trials:Currently Recruiting for 2 Trials
Experienced in Hypophosphatasia (HPP)
Saint Petersburg, SPE, RU 
OverviewLocationsClinical Research

Overview

Mikhail Kostik practices in Saint Petersburg, Russian Federation. Kostik is rated as an Experienced expert by MediFind in the treatment of Hypophosphatasia (HPP). Their top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Osteomyelitis, Osteomyelitis in Children, Multisystem Inflammatory Syndrome in Children (MIS-C), and Tissue Biopsy.

Their clinical research consists of co-authoring 84 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hypophosphatasia (HPP).

Locations

Saint Petersburg, SPE, Russian Federation
Other Locations
Moscow, MOW, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An International Multicenter Open-label Clinical Study of the Safety and Efficacy of RPH-104 for Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
An International Multicenter Open-label Clinical Study of the Safety and Efficacy of RPH-104 for Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
Enrollment Status: Recruiting
Publish Date: December 16, 2024
Intervention Type: Biological
Study Drug: RPH-104
Study Phase: Phase 2
Chronic Childhood Vasculitis: Characterizing the Individual Rare Diseases to Improve Patient Outcomes
Chronic Childhood Vasculitis: Characterizing the Individual Rare Diseases to Improve Patient Outcomes
Enrollment Status: Recruiting
Publish Date: November 30, 2023
International, Multicenter, Double Blind, Placebo-controlled, Randomized Clinical Study of Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
International, Multicenter, Double Blind, Placebo-controlled, Randomized Clinical Study of Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
Enrollment Status: Active_not_recruiting
Publish Date: December 06, 2024
Intervention Type: Biological, Drug
Study Drug: RPH-104
Study Phase: Phase 2
View 1 Less Clinical Trial

84 Total Publications

Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient
Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient
Journal: Turkish archives of pediatrics
Published: October 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kostik's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 23 Advanced Conditions
View All 66 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile